Cystic fibrosis-related diabetes: Prevalence, screening, and diagnosis.

Khare, Swapnil; Desimone, Marisa; Kasim, Nader; Chan, Christine L

Khare, Swapnil; Desimone, Marisa; Kasim, Nader; Chan, Christine L.

Affiliation

Khare S; Division of Endocrinology, Diabetes and Metabolism, Indiana University-Purdue University, Indianapolis, IN, United States.
Desimone M; Division of Endocrinology, Diabetes and Metabolism SUNY, Upstate Medical University, Syracuse, NY, United States.
Kasim N; Division of Pediatric Endocrinology, Michigan State University, Helen Devos Children's Hospital/Spectrum Health, Grand Rapids, MI, United States.
Chan CL; Department of Pediatrics, Division of Pediatric Endocrinology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.

J Clin Transl Endocrinol ; 27: 100290, 2022 Mar.

Article in En | MEDLINE | ID: mdl-34917485

Key words

1hG, 1 h glucose; 2hG, 2 h glucose; A1c, Hemoglobin A1c; CF, Cystic Fibrosis; CFRD, Cystic Fibrosis Related Diabetes; Continuous glucose monitoring; Cystic fibrosis-related diabetes; FPG, Fasting Plasma Glucose; Hemoglobin A1c; OGTT, Oral glucose tolerance testing; Oral glucose tolerance test; Prevalence; Screening; T1DM, Type 1 diabetes mellitus; T2DM, Type 2 diabetes mellitus

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Prevalence_studies / Risk_factors_studies / Screening_studies Language: En Journal: J Clin Transl Endocrinol Year: 2022 Document type: Article Affiliation country: United States Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google